Louis S. Harris
Affiliations: | Virginia Commonwealth University School of Medicine, Richmond, VA |
Area:
Pharmacology, opioid, pain, analgesicsWebsite:
http://www.vcu.edu/pharmtox/about/history.htmGoogle:
"Louis Harris"Mean distance: 16.45 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| Frederick C. Uhle | grad student | 1958 | Harvard Medical School (Chemistry Tree) |
Children
Sign in to add trainee| William L. Dewey | grad student | ||
| R. Adron Harris | grad student | 1973 | UNC Chapel Hill |
| Kenneth M. Johnson | post-doc | VCU School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Walentiny D, Harris L. (2015) Characterization of morphine discriminative stimulus properties in C57BL/6 mice Drug and Alcohol Dependence. 146: e15 |
| Ben Haddou T, Malfacini D, Calo G, et al. (2014) Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor. Molecular Pain. 10: 48 |
| Moynihan HA, Derrick I, Broadbear JH, et al. (2012) Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects. Journal of Medicinal Chemistry. 55: 9868-74 |
| Wise LE, Premaratne ID, Gamage TF, et al. (2012) l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice. Pharmacology, Biochemistry, and Behavior. 103: 245-52 |
| Follia V, Aceto MD, Harris LS, et al. (2011) Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities Bmc Pharmacology. 11: A26 |
| Kwilasz AJ, Harris LS, Vann RE. (2009) Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice. Pharmacology, Biochemistry, and Behavior. 94: 114-8 |
| Cami-Kobeci G, Neal AP, Bradbury FA, et al. (2009) Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines. Journal of Medicinal Chemistry. 52: 1546-52 |
| Metcalf MD, Aceto MD, Harris LS, et al. (2008) The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73 |
| Hiebel AC, Lee YS, Bilsky E, et al. (2007) Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series. Journal of Medicinal Chemistry. 50: 3765-76 |
| Naidu PS, Lichtman AH, Archer CC, et al. (2007) NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. European Journal of Pharmacology. 566: 132-6 |